0001493152-24-001394.txt : 20240105
0001493152-24-001394.hdr.sgml : 20240105
20240105160030
ACCESSION NUMBER: 0001493152-24-001394
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240103
FILED AS OF DATE: 20240105
DATE AS OF CHANGE: 20240105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Finley John David
CENTRAL INDEX KEY: 0001851034
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33672
FILM NUMBER: 24516135
MAIL ADDRESS:
STREET 1: C/O SENECA BIOPHARMA, INC.
STREET 2: 20271 GOLDENROD LANE
CITY: GERMANTOWN
STATE: MD
ZIP: 20876
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PALISADE BIO, INC.
CENTRAL INDEX KEY: 0001357459
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 522007292
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7750 EL CAMINO REAL, SUITE 5200
CITY: CARLSBAD
STATE: CA
ZIP: 92009
BUSINESS PHONE: (858) 704-4900
MAIL ADDRESS:
STREET 1: 7750 EL CAMINO REAL, SUITE 5200
CITY: CARLSBAD
STATE: CA
ZIP: 92009
FORMER COMPANY:
FORMER CONFORMED NAME: Seneca Biopharma, Inc.
DATE OF NAME CHANGE: 20200127
FORMER COMPANY:
FORMER CONFORMED NAME: Neuralstem, Inc.
DATE OF NAME CHANGE: 20060324
4
1
ownership.xml
X0508
4
2024-01-03
0
0001357459
PALISADE BIO, INC.
PALI
0001851034
Finley John David
7750 EL CAMINO REAL, SUITE 2A
CARLSBAD,
CA
92009
1
1
0
0
CEO, CFO, Director
0
Common Stock, par value $0.01
2024-01-03
4
M
0
1309
0.00
A
64649
D
Common Stock, par value $0.01
777
I
By FCW Investments, LLC
Restricted Stock Units
2024-01-03
4
M
0
1309
D
Common Stock
1309
0
D
Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units.
Reporting Person is the managing member of FCW Investments LLC and has the sole investment and voting power over the securities held by this entity.
This restricted stock unit was granted on January 3, 2023 and 1,309 restricted stock units subject to the award vested on January 3, 2024. There are no additional restricted stock units underlying this grant.
Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
/s/ JD Finley
2024-01-05